Achieve Life Sciences
ACHV
ACHV
31 hedge funds and large institutions have $16.6M invested in Achieve Life Sciences in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
11% more funds holding
Funds holding: 28 → 31 (+3)
6.82% less ownership
Funds ownership: 20.59% → 13.78% (-6.8%)
Holders
31
Holding in Top 10
–
Calls
$2.32M
Puts
$420K
Top Buyers
| 1 | +$990K | |
| 2 | +$952K | |
| 3 | +$647K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$598K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$538K |
Top Sellers
| 1 | -$550K | |
| 2 | -$328K | |
| 3 | -$75K | |
| 4 |
CC
Clearline Capital
New York
|
-$66.5K |
| 5 |
Morgan Stanley
New York
|
-$66.3K |